Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Study Overview Bristol-Myers Squibb is launching a late-stage study to test a new treatment combo, KarXT plus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results